DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes

Epigenomics

Volumn 6, Issue 2, 2014, Pages 179-191

  Farkas, Sanja A ^a,b   Vymetalkova, Veronika ^c,d   Vodickova, Ludmila ^c,d   Vodicka, Pavel ^c,d   Nilsson, Torbjörn K ^e  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

CpG; DNA repair genes; Infinium Human Methylation 450 BeadChip; methylation status; sporadic colorectal cancer; Wnt catenin signaling pathway

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CASPASE 8; CYCLIN H; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MESSENGER RNA; SMAD2 PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 1; WNT PROTEIN; WNT2 PROTEIN; WNT3A PROTEIN; WNT6 PROTEIN; DCLRE1C PROTEIN, HUMAN; GLYPICAN; GPC6 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CTNNB1 GENE; DCLRE1C GENE; DKK2 GENE; DKK3 GENE; DNA DAMAGE; DNA END JOINING REPAIR; DNA METHYLATION; DNA MICROARRAY; DNA REPAIR; EDNRB1 GENE; EXCISION REPAIR; FEMALE; FZD5 GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GPC6 GENE; GTF2H5 GENE; HIGH RESOLUTION MELTING ANALYSIS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; KIAA1804 GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISMATCH REPAIR; MYO1B GENE; NEIL1 GENE; NEIL3 GENE; NHEJ1 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TLE3 GENE; TTN GENE; TUMOR LOCALIZATION; WNT SIGNALING PATHWAY; BIOSYNTHESIS; COLORECTAL TUMOR; CPG ISLAND; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; PROMOTER REGION;

AGED; BETA CATENIN; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA REPAIR; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84900412412     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.14.7     Document Type: Article

References (51)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin.55(2), 74-108 (2005).
2. Polakova V, Pardini B, Naccarati A et al. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum. Mutat.30(4), 661-668 (2009).
3. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology50(1), 113-130 (2007). (Pubitemid 44953403)
4. Beggs AD, Domingo E, Abulafi M, Hodgson SV, Tomlinson IP. A study of genomic instability in early preneoplastic colonic lesions. Oncogene.32(46), 5333-5337 (2013).
5. Ahnen DJ. The American College of Gastroenterology Emily Couric Lecture-the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived? Am. J. Gastroenterol.106(2), 190-198 (2011).
6. Feinberg AP. The epigenetics of cancer etiology. Semin. Cancer Biol.14(6), 427-432 (2004). (Pubitemid 39360990)
7. Knudson AG. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer1(2), 157-162 (2001). (Pubitemid 33741891)
8. Segditsas S, Rowan AJ, Howarth K et al. APC and the three-hit hypothesis. Oncogene28(1), 146-155 (2009).
9. Zitt M, Müller HM. DNA methylation in colorectal cancer-impact on screening and therapy monitoring modalities? Dis. Markers.23(1-2), 51-71 (2007). (Pubitemid 46333641)
10. Naumov VA, Generozov EV, Zaharjevskaya NB et al. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics.8(9), 921-934 (2013).
11. Beggs AD, Jones A, El-Bahwary M, Abulafi M, Hodgson SV, Tomlinson IP. Whole-genome methylation analysis of benign and malignant colorectal tumours. J. Pathol.229(5), 697-704 (2013).
12. Network CGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature.487(7407), 330-337 (2012).
13. Hinoue T, Weisenberger DJ, Lange CP et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res.22(2), 271-282 (2012).
14. Irizarry R, Ladd-Acosta C, Wen B et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet.41(2), 178-186 (2009).
15. Slyskova J, Korenkova V, Collins AR et al. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas. Clin. Cancer Res.18(21), 5878-5887 (2012).
16. Sandoval J, Heyn HA, Moran S et al. Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics6(6), 692-702 (2011).
17. Bibikova M, Barnes B, Tsan C et al. High density DNA methylation array with single CpG site resolution. Genomics98(4), 288-295 (2011).
18. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: wnt signaling in cancer. Biochim. Biophys. Acta1653(1), 1-24 (2003). (Pubitemid 36627817)
19. Human DNA repair genes. http://sciencepark.mdanderson.org/labs/wood/dna- repair-genes.html
20. Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics22(1), 7-12 (2006). (Pubitemid 43057002)
21. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics5(4), 557-572 (2004). (Pubitemid 41180205)
22. Rasmussen M, Sundstrom M, Kultima HG et al. Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity. Genome Biol. 12(10), R108 (2011).
23. Uddin S, Ahmed M, Hussain A et al. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J. Pathol.178(2), 537-547 (2011).
24. NCBI. www.ncbi.nlm.nih.gov/geo/geo2r
25. Wang D, Yan L, Hu Q et al. IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data. Bioinformatics28(5), 729-730 (2012).
26. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol.3, (2004). Article3
27. Tsai HC, Baylin SB. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 21(3), 502-517 (2011).
28. Carmona FJ, Azuara D, Berenguer-Llergo A et al. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev. Res. (Phila.)6(7), 656-665 (2013).
29. Ordway JM, Bedell JA, Citek RW et al. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis27(12), 2409-2423 (2006). (Pubitemid 44884098)
30. Goeppert B, Konermann C, Schmidt CR et al. Global alterations of DNA methylation in cholangiocarcinoma targets the Wnt signaling pathway. Hepatology59(2), 544-554 (2014).
31. Bizama C, Benavente F, Salvatierra E et al. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer. Int. J. Cancer134(4), 755-764 (2014).
32. Sato H, Suzuki H, Toyota M et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis28(12), 2459-2466 (2007). (Pubitemid 350238947)
33. Nilsson TK, Löf-Öhlin ZM, Sun XF. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. Int. J. Oncol.42(1), 127-133 (2013).
34. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol.6(4), 308-317 (2006).
35. Kim HS, Lee JW, Soung YH et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology125(3), 708-715 (2003). (Pubitemid 37070689)
36. Soung YH, Lee JW, Kim SY et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225-1226delTG in hepatocellular carcinomas. Oncogene24(1), 141-147 (2005). (Pubitemid 40143873)
37. Cho S, Lee JH, Cho SB et al. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. Pathol. Int.60(3), 203-211 (2010).
38. Skiriute D, Vaitkiene P, Saferis V et al. MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma. BMC Cancer12, 218 (2012).
39. Wu Y, Alvarez M, Slamon DJ, Koeffler P, Vadgama JV. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer10, 32 (2010).
40. Sánchez-Vega F, Gotea V, Petrykowska HM et al. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines. Epigenetics8(12), 1355-1372 (2013).
41. Jabeen R, Babar ME, Ahmad J, Awan AR. Novel mutations of endothelin-B receptor gene in Pakistani patients with Waardenburg syndrome. Mol. Biol. Rep.39(1), 785-788 (2012).
42. Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int. J. Cancer98(5), 651-655 (2002). (Pubitemid 34225614)
43. Tao K, Wu C, Wu K et al. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer. Med. Oncol.29(1), 107-112 (2012).
44. Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol. Rep.15(2), 507-511 (2006).
45. Filmus J, Capurro M, Rast J. Glypicans. Genome Biol.9(5), 224 (2008).
46. Lau CS, Yu CB, Wong HK et al. Allelic imbalance at 13q31 is associated with reduced GPC6 in Chinese with sporadic retinoblastoma. Br. J. Ophthalmol.94(3), 357-362 (2010).
47. Yiu GK, Kaunisto A, Chin YR, Toker A. NFAT promotes carcinoma invasive migration through glypican-6. Biochem. J.440(1), 157-166 (2011).
48. Fleming NI, Jorissen RN, Mouradov D et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res.73(2), 725-735 (2013).
49. Papageorgis P, Lambert AW, Ozturk S et al. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res.70(3), 968-978 (2010).
50. Kulis M, Queirós AC, Beekman R, Martín-Subero JI. Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. Biochim. Biophys. Acta1829(11), 1161-1174 (2013).
51. Nordlund J, Bäcklin CL, Wahlberg P et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol.14(9), r105 (2013).